Literature DB >> 18040761

Pharmaceutical particle engineering via spray drying.

Reinhard Vehring1.   

Abstract

This review covers recent developments in the area of particle engineering via spray drying. The last decade has seen a shift from empirical formulation efforts to an engineering approach based on a better understanding of particle formation in the spray drying process. Microparticles with nanoscale substructures can now be designed and their functionality has contributed significantly to stability and efficacy of the particulate dosage form. The review provides concepts and a theoretical framework for particle design calculations. It reviews experimental research into parameters that influence particle formation. A classification based on dimensionless numbers is presented that can be used to estimate how excipient properties in combination with process parameters influence the morphology of the engineered particles. A wide range of pharmaceutical application examples -- low density particles, composite particles, microencapsulation, and glass stabilization -- is discussed, with specific emphasis on the underlying particle formation mechanisms and design concepts.

Mesh:

Substances:

Year:  2007        PMID: 18040761      PMCID: PMC2292490          DOI: 10.1007/s11095-007-9475-1

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  275 in total

Review 1.  The role of particle properties in pharmaceutical powder inhalation formulations.

Authors:  Nora Y K Chew; Hak-Kim Chan
Journal:  J Aerosol Med       Date:  2002

2.  Activity-stability considerations of trypsinogen during spray drying: effects of sucrose.

Authors:  S T Tzannis; S J Prestrelski
Journal:  J Pharm Sci       Date:  1999-03       Impact factor: 3.534

Review 3.  Pulmonary insulin delivery--state of the art 2007.

Authors:  Jay S Skyler
Journal:  Diabetes Technol Ther       Date:  2007-06       Impact factor: 6.118

4.  Novel lipid-based hollow-porous microparticles as a platform for immunoglobulin delivery to the respiratory tract.

Authors:  A I Bot; T E Tarara; D J Smith; S R Bot; C M Woods; J G Weers
Journal:  Pharm Res       Date:  2000-03       Impact factor: 4.200

Review 5.  First approved inhaled insulin therapy for diabetes mellitus.

Authors:  Rucha Jani; Curtis Triplitt; Charles Reasner; Ralph A Defronzo
Journal:  Expert Opin Drug Deliv       Date:  2007-01       Impact factor: 6.648

6.  Fast-dissolving mucoadhesive microparticulate delivery system containing piroxicam.

Authors:  Francesco Cilurzo; Francesca Selmin; Paola Minghetti; Isabella Rimoldi; Francesco Demartin; Luisa Montanari
Journal:  Eur J Pharm Sci       Date:  2005-03       Impact factor: 4.384

7.  Characterization of suspension-based metered dose inhaler formulations composed of spray-dried budesonide microcrystals dispersed in HFA-134a.

Authors:  Thomas E Tarara; Michael S Hartman; Howard Gill; Alan A Kennedy; Jeffry G Weers
Journal:  Pharm Res       Date:  2004-09       Impact factor: 4.200

8.  Mucoadhesive microspheres containing gentamicin sulfate for nasal administration: preparation and in vitro characterization.

Authors:  Canan Hasçiçek; Nurşin Gönül; Nevin Erk
Journal:  Farmaco       Date:  2003-01

9.  Pulmonary delivery of growth hormone using dry powders and visualization of its local fate in rats.

Authors:  Cynthia Bosquillon; Véronique Préat; Rita Vanbever
Journal:  J Control Release       Date:  2004-04-28       Impact factor: 9.776

10.  Cationic stearylamine-containing biodegradable microparticles for DNA delivery.

Authors:  C Kusonwiriyawong; K Atuah; O H Alpar; H P Merkle; E Walter
Journal:  J Microencapsul       Date:  2004-02       Impact factor: 3.142

View more
  160 in total

1.  Release profile and characteristics of electrosprayed particles for oral delivery of a practically insoluble drug.

Authors:  Adam Bohr; Jakob Kristensen; Mark Dyas; Mohan Edirisinghe; Eleanor Stride
Journal:  J R Soc Interface       Date:  2012-04-25       Impact factor: 4.118

2.  Preparation and in vitro aerosol performance of spray-dried Shuang-Huang-Lian corrugated particles in carrier-based dry powder inhalers.

Authors:  Jing-Jing Yang; Chun-Yu Liu; Li-Hui Quan; Yong-Hong Liao
Journal:  AAPS PharmSciTech       Date:  2012-05-30       Impact factor: 3.246

3.  Analysis of process parameters affecting spray-dried oily core nanocapsules using factorial design.

Authors:  Tao Zhang; Bi-Botti C Youan
Journal:  AAPS PharmSciTech       Date:  2010-09-15       Impact factor: 3.246

4.  One-step production of protein-loaded PLGA microparticles via spray drying using 3-fluid nozzle.

Authors:  Feng Wan; Morten Jonas Maltesen; Sune Klint Andersen; Simon Bjerregaard; Camilla Foged; Jukka Rantanen; Mingshi Yang
Journal:  Pharm Res       Date:  2014-02-19       Impact factor: 4.200

5.  Isoxyl aerosols for tuberculosis treatment: preparation and characterization of particles.

Authors:  Chenchen Wang; Anthony J Hickey
Journal:  AAPS PharmSciTech       Date:  2010-03-26       Impact factor: 3.246

6.  Formulation and evaluation of carrier-free dry powder inhaler containing sildenafil.

Authors:  Thi-Tram Nguyen; Eun-Jin Yi; Kyu-Mok Hwang; Cheol-Hee Cho; Chun-Woong Park; Ju-Young Kim; Yun-Seok Rhee; Eun-Seok Park
Journal:  Drug Deliv Transl Res       Date:  2019-02       Impact factor: 4.617

7.  Rational design of multistage drug delivery vehicles for pulmonary RNA interference therapy.

Authors:  A Sofia Silva; Kevin E Shopsowitz; Santiago Correa; Stephen W Morton; Erik C Dreaden; Teresa Casimiro; Ana Aguiar-Ricardo; Paula T Hammond
Journal:  Int J Pharm       Date:  2020-10-26       Impact factor: 5.875

8.  Formulation of High-Performance Dry Powder Aerosols for Pulmonary Protein Delivery.

Authors:  Erin M Wilson; J Christopher Luft; Joseph M DeSimone
Journal:  Pharm Res       Date:  2018-08-23       Impact factor: 4.200

9.  A spray-drying strategy for synthesis of nanoscale metal-organic frameworks and their assembly into hollow superstructures.

Authors:  Arnau Carné-Sánchez; Inhar Imaz; Mary Cano-Sarabia; Daniel Maspoch
Journal:  Nat Chem       Date:  2013-02-10       Impact factor: 24.427

10.  Nanocomposite microparticles (nCmP) for the delivery of tacrolimus in the treatment of pulmonary arterial hypertension.

Authors:  Zimeng Wang; Julie L Cuddigan; Sweta K Gupta; Samantha A Meenach
Journal:  Int J Pharm       Date:  2016-08-26       Impact factor: 5.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.